8-K: 22nd Century Group Announces Participation in Emerging Growth Virtual Conference

22nd Century Group will provide a corporate update at the Emerging Growth Virtual Conference on August 21, 2024.

Summary

• 22nd Century Group, a tobacco products company focused on nicotine harm reduction, will participate in the Emerging Growth Virtual Conference on August 21, 2024.
• The company will provide a brief corporate update at 4:25 PM Eastern Time.
• 22nd Century Group is focused on tobacco harm reduction by offering products with 95% less nicotine.
• They have developed proprietary reduced nicotine content (RNC) tobacco plants and clinically validated RNC cigarette products.
• The company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021.
• They are also a participating manufacturer under the Master Settlement Agreement (MSA) and have contract manufacturing operations.

Sentiment

Score: 7

Explanation: The document is a positive announcement of investor engagement and highlights the company's unique position in the reduced-risk tobacco market. There are no negative aspects mentioned.

Positives

• The company is actively engaging with investors through the Emerging Growth Virtual Conference.
• 22nd Century Group is a leader in reduced nicotine tobacco products.
• The company has a unique FDA MRTP authorization for a combustible cigarette.
• They have a vertically integrated business model.

Risks

• The company operates in a highly regulated industry, which could impact future growth.
• Consumer acceptance of reduced nicotine products may be a challenge.

Future Outlook

The company will provide a corporate update at the Emerging Growth Virtual Conference, but no specific forward-looking statements are included in this document.

Management Comments

• The company will provide a brief corporate update as part of the Emerging Growth Virtual Conference.

Industry Context

The announcement highlights 22nd Century Group's continued efforts in the tobacco harm reduction space, which is a growing area of focus within the industry due to increasing health concerns and regulatory pressures.

Comparison to Industry Standards

• While many tobacco companies are exploring reduced-risk products, 22nd Century Group stands out with its FDA MRTP authorization for a combustible cigarette, a unique achievement.
• Other companies like Philip Morris International with their IQOS product and British American Tobacco with their Vuse products are also focused on reduced risk products, but these are not combustible cigarettes.
• The company's focus on vertically integrated production and contract manufacturing is also a differentiator compared to some competitors who rely more on third-party manufacturing.

Stakeholder Impact

• Shareholders will receive an update on the company's progress at the conference.
• Potential investors will have an opportunity to learn more about the company.
• Customers may be interested in the company's reduced nicotine products.

Next Steps

• 22nd Century Group will present at the Emerging Growth Virtual Conference on August 21, 2024.
• Investors can access the live presentation online.

Key Dates

Keywords

tobacco harm reduction, reduced nicotine, MRTP, contract manufacturing, virtual conference, biotechnology, nicotine